Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device

Status Withdrawn

Clinical Trial Summary

This study observes the continuous measurement of breathing patterns, heart rate, restlessness, and tremor in sleep using the EarlySense ES 16 device as a tool in the management of hypoglycemia in pediatric type I diabetes patients.

Clinical Trial Description

The study patients are children, 12-18 years old, suffering from type I diabetes. Each patient will participate in the trial for 30 days.

During this period of time the patients' breathing patterns, heart rate, restlessness and tremor in sleep will be measured by the EarlySense device which is put in the patient's bed. These measured values will be compared to:

1. glucose values measured by a "Guardian RT" device - an approved device for CBGM - Continuous Blood Glucose Measurement;

2. glucose levels tested by SBGM -Self Blood Glucose Measurement.

These comparisons will show whether the EarlySense device is applicable in predicting hypoglycemia events in type I diabetes patients. ;

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00361608
Study type	Observational
Source	EarlySense Ltd.
Contact
Status	Withdrawn
Phase	N/A
Start date	July 2008
Completion date	May 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05160142` - Diabetes Inspired Culinary Education	Early Phase 1
Withdrawn	`NCT05035368` - Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes	Phase 2
Completed	`NCT01928329` - A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes	Phase 2
Completed	`NCT02127762` - The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy	N/A
Completed	`NCT00999375` - Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)	Phase 2
Completed	`NCT04279613` - A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041	Phase 1
Not yet recruiting	`NCT02117518` - Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients	N/A
Withdrawn	`NCT01477476` - Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes	Phase 2
Terminated	`NCT01308437` - Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics	Phase 3
Terminated	`NCT01652911` - A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation	Phase 1/Phase 2
Completed	`NCT06242548` - How Type I Diabetes Responds to Different Diets (Normoglucidic or Ketogenic) During Physical Activity at Altitude	N/A
Completed	`NCT00351650` - Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan	N/A
Terminated	`NCT03653533` - Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump	N/A
Completed	`NCT00340639` - Management of Type 1 Diabetes Among Adolescents	N/A
Completed	`NCT02634216` - Effects of Capros in Patients With Type-1 Diabetes	N/A
Completed	`NCT02002130` - The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes	Phase 1
Withdrawn	`NCT01623388` - Epigenetic Modifications of Diabetes Mellitus Type I	N/A
Completed	`NCT02612493` - Obesity and Metabolic Surgery in Patients With Type I Diabetes	N/A
Completed	`NCT01843114` - Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects	N/A
Withdrawn	`NCT01398670` - Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics	Phase 3